Reagan-Udall Foundation Approaches The Starting Line; Next Step Is Funding
Executive Summary
The FDA Amendments Act, which reauthorized the user fee program and gave FDA broad new powers to ensure drug safety, has given the agency an abundance of oversight functions to organize, but also has provided the agency an outside partner: The Reagan-Udall Foundation
You may also be interested in...
FDA Amendments Act’s One-Year Anniversary: For Better Or Worse
At the one-year anniversary of the FDA Amendments Act, the agency's record is mixed in meeting its increased responsibilities and authorities the law requires
FDA Amendments Act’s One-Year Anniversary: For Better Or Worse
At the one-year anniversary of the FDA Amendments Act, the agency's record is mixed in meeting its increased responsibilities and authorities the law requires
FDA’s Pharmacoepidemiology Studies Could Be Funded Through Reagan-Udall
The Reagan-Udall Foundation could fund and select investigators for post-market pharmacoepidemiological studies on behalf of the FDA, a participant at an agency workshop suggested